Germany's DHL to acquire US pharma logistics firm Cryopdp
This is part of the German company’s efforts to grow its operations in the pharma sector
Add BT as a preferred source
[DUSSELDORF, Germany] DHL said on Monday (Mar 31) it will acquire US pharmaceutical logistics firm Cryopdp as part of the German company’s efforts to grow its operations in the pharma sector, confirming an earlier report by Reuters.
DHL did not disclose a purchase price for the deal, which foresees the German logistics giant buying 100 per cent of the specialty courier. A source familiar with the matter told Reuters that DHL would pay a three-digit million-euro sum.
The companies have also agreed to a strategic partnership to strengthen their supply chain service offerings for the global life sciences and healthcare sector, DHL said in a statement.
Cryopdp ships products for pharmaceutical and biotech companies, as well as offering storage and packaging services.
DHL hopes the deal will strengthen its Life Sciences and Healthcare segments, which generated over US$5.41 billion in revenue in 2024.
The deal and the outlined partnership are subject to regulatory approvals, the company said. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Malaysia’s 8th richest man Jeffrey Cheah wants Sunway business to last 10 generations
Will the Philippines hit the brakes on a deregulated oil industry amid fuel pain?
Strengthening Asean’s economic resilience through RCEP’s 2027 review
How China’s young workers are securing their future even as AI disrupts job market, triggers pay cuts
